Hyper‐arrangement and CDKN2A (cyclin‐dependent kinase inhibitor 2A) deletion are associated with increased proliferation of tumor cells [12], reflecting active tumor growth and suggesting poor patient outcomes. This evidence concerns the gene CDKN2A and neoplasm.